Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $14.00 | 1 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dermavant Sciences, Inc. | $14.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $14.00 | 1 | Dermavant Sciences, Inc. ($14.00) |
All Payment Transactions
1 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/28/2022 | Dermavant Sciences, Inc. | VTAMA (Drug) | Education | In-kind items and services | $14.00 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,933 | 2,918 | $674,351 | $118,868 |
| 2022 | 9 | 2,034 | 3,099 | $661,306 | $119,337 |
| 2021 | 10 | 2,085 | 3,229 | $636,725 | $127,458 |
| 2020 | 9 | 1,842 | 2,859 | $550,772 | $99,090 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 628 | 848 | $232,806 | $41,450 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 413 | 506 | $204,768 | $38,236 | 18.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 337 | 474 | $112,519 | $20,575 | 18.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 78 | 89 | $25,813 | $4,910 | 19.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 140 | 149 | $23,400 | $3,783 | 16.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $22,681 | $3,737 | 16.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 39 | 39 | $14,139 | $2,509 | 17.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 58 | 67 | $9,916 | $1,834 | 18.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 192 | 698 | $24,985 | $1,182 | 4.7% |
| 17260 | Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less | Office | 2023 | 11 | 11 | $3,324 | $652.17 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 655 | 895 | $241,282 | $44,753 | 18.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 376 | 445 | $177,221 | $32,943 | 18.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 378 | 522 | $118,836 | $23,388 | 19.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 87 | 93 | $25,863 | $4,960 | 19.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 147 | 164 | $26,438 | $3,944 | 14.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 54 | 54 | $18,306 | $3,289 | 18.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 103 | 114 | $16,412 | $3,102 | 18.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $9,088 | $1,593 | 17.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 218 | 796 | $27,860 | $1,364 | 4.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 461 | 582 | $198,652 | $43,331 | 21.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 572 | 745 | $169,334 | $39,575 | 23.4% |
| 17000 | Destruction of skin growth | Office | 2021 | 387 | 564 | $128,712 | $24,083 | 18.7% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 137 | 152 | $43,529 | $6,585 | 15.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 34 | 34 | $18,134 | $3,836 | 21.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 130 | 140 | $22,820 | $3,245 | 14.2% |
About Dr. Mitchell Rubenstein, MD
Dr. Mitchell Rubenstein, MD is a Dermatology healthcare provider based in Brookline, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003873126.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Rubenstein, MD has received a total of $14.00 in payments from pharmaceutical and medical device companies, with $14.00 received in 2022. These payments were reported across 1 transactions from 1 company. The most common payment nature is "Education" ($14.00).
As a Medicare-enrolled provider, Rubenstein has provided services to 7,894 Medicare beneficiaries, totaling 12,105 services with total Medicare billing of $464,753. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Brookline, MA
- Active Since 05/01/2006
- Last Updated 05/31/2012
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1003873126
Products in Payments
- VTAMA (Drug) $14.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Brookline
Rachael Clark, Md Phd, MD PHD
Dermatology — Payments: $13,305
Dr. Neil Houston, Md, MD
Dermatology — Payments: $11,136
Dr. Miaoyuan Wang, M.d, M.D
Dermatology — Payments: $8,323
Alan Rockoff, M.d, M.D
Dermatology — Payments: $1,432
Dorothy Cunningham, Md, MD
Dermatology — Payments: $811.92
David Taub, Md, MD
Dermatology — Payments: $140.22